135 related articles for article (PubMed ID: 25050790)
1. Semi-physiological pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for thrombocytopenia in rats.
Kobuchi S; Ito Y; Hayakawa T; Nishimura A; Shibata N; Takada K; Sakaeda T
Xenobiotica; 2015 Jan; 45(1):19-28. PubMed ID: 25050790
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for erythropenia in rats.
Kobuchi S; Ito Y; Hayakawa T; Nishimura A; Shibata N; Takada K; Sakaeda T
J Pharmacol Toxicol Methods; 2014; 70(2):134-44. PubMed ID: 25072509
[TBL] [Abstract][Full Text] [Related]
3. Semi-physiological pharmacokinetic-pharmacodynamic modeling and simulation of 5-fluorouracil for the whole time course of alterations in leukocyte, neutrophil and lymphocyte counts in rats.
Kobuchi S; Ito Y; Hayakawa T; Kuwano S; Baba A; Shinohara K; Nishimura A; Shibata N; Takada K
Xenobiotica; 2014 Sep; 44(9):804-18. PubMed ID: 24650147
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetic-Pharmacodynamic Modeling of 5-Fluorouracil for Toxicities in Rats.
Kobuchi S; Ito Y; Sakaeda T
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):707-718. PubMed ID: 27889876
[TBL] [Abstract][Full Text] [Related]
5. A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer.
Bender BC; Schaedeli-Stark F; Koch R; Joshi A; Chu YW; Rugo H; Krop IE; Girish S; Friberg LE; Gupta M
Cancer Chemother Pharmacol; 2012 Oct; 70(4):591-601. PubMed ID: 22886072
[TBL] [Abstract][Full Text] [Related]
6. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of oxaliplatin for hematological toxicity in rats.
Kobuchi S; Katsuyama Y; Ito Y
Xenobiotica; 2020 Feb; 50(2):223-230. PubMed ID: 30938550
[TBL] [Abstract][Full Text] [Related]
7. Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric Ependymoma.
Daryani VM; Patel YT; Tagen M; Turner DC; Carcaboso AM; Atkinson JM; Gajjar A; Gilbertson RJ; Wright KD; Stewart CF
CPT Pharmacometrics Syst Pharmacol; 2016 Apr; 5(4):211-221. PubMed ID: 27104090
[TBL] [Abstract][Full Text] [Related]
8. Semiphysiological model for the time course of leukocytes after varying schedules of 5-fluorouracil in rats.
Friberg LE; Freijs A; Sandström M; Karlsson MO
J Pharmacol Exp Ther; 2000 Nov; 295(2):734-40. PubMed ID: 11046112
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia.
Kaefer A; Yang J; Noertersheuser P; Mensing S; Humerickhouse R; Awni W; Xiong H
Cancer Chemother Pharmacol; 2014 Sep; 74(3):593-602. PubMed ID: 25053389
[TBL] [Abstract][Full Text] [Related]
10. Population analysis of the pharmacokinetics and the haematological toxicity of the fluorouracil-epirubicin-cyclophosphamide regimen in breast cancer patients.
Sandström M; Lindman H; Nygren P; Johansson M; Bergh J; Karlsson MO
Cancer Chemother Pharmacol; 2006 Aug; 58(2):143-56. PubMed ID: 16465545
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic model for chemoradiotherapy-induced thrombocytopenia in mice.
Krzyzanski W; Perez-Ruixo JJ; Harrold J
J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):709-20. PubMed ID: 26341875
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic/pharmacodynamic modeling of 5-fluorouracil by using a biomarker to predict tumor growth in a rat model of colorectal cancer.
Kobuchi S; Ito Y; Okada K; Imoto K; Kuwano S; Takada K
J Pharm Sci; 2013 Jun; 102(6):2056-2067. PubMed ID: 23592368
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetic/Pharmacodynamic Analyses of Avatrombopag in Patients With Chronic Liver Disease and Optimal Dose Adjustment Guide With Concomitantly Administered CYP3A and CYP2C9 Inhibitors.
Nomoto M; Ferry J; Hussein Z
J Clin Pharmacol; 2018 Dec; 58(12):1629-1638. PubMed ID: 29905956
[TBL] [Abstract][Full Text] [Related]
14. A predictive biomarker for altered 5-fluorouracil pharmacokinetics following repeated administration in a rat model of colorectal cancer.
Kobuchi S; Kuwano S; Imoto K; Okada K; Nishimura A; Ito Y; Shibata N; Takada K
Biopharm Drug Dispos; 2013 Oct; 34(7):365-76. PubMed ID: 23836081
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of a semimechanistic-physiologic population PK/PD model for neutropenia following pemetrexed therapy.
Latz JE; Rusthoven JJ; Karlsson MO; Ghosh A; Johnson RD
Cancer Chemother Pharmacol; 2006 Apr; 57(4):427-35. PubMed ID: 16322992
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic model for chemotherapy-induced anemia in rats.
Woo S; Krzyzanski W; Jusko WJ
Cancer Chemother Pharmacol; 2008 Jun; 62(1):123-33. PubMed ID: 17891399
[TBL] [Abstract][Full Text] [Related]
17. Haematological toxicity following different dosing schedules of 5-fluorouracil and epirubicin in rats.
Simonsen LE; Wählby U; Sandström M; Freijs A; Karlsson MO
Anticancer Res; 2000; 20(3A):1519-25. PubMed ID: 10928065
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic/pharmacodynamic modelling-based optimisation of administration schedule for the histone deacetylase inhibitor abexinostat (S78454/PCI-24781) in phase I.
Fouliard S; Robert R; Jacquet-Bescond A; du Rieu QC; Balasubramanian S; Loury D; Loriot Y; Hollebecque A; Kloos I; Soria JC; Chenel M; Depil S
Eur J Cancer; 2013 Sep; 49(13):2791-7. PubMed ID: 23790467
[TBL] [Abstract][Full Text] [Related]
19. Model-based neutrophil-guided dose adaptation in chemotherapy: evaluation of predicted outcome with different types and amounts of information.
Wallin JE; Friberg LE; Karlsson MO
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):234-42. PubMed ID: 20050841
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different pharmacodynamic models for PK-PD modeling of verapamil in renovascular hypertension.
Bertera FM; Mayer MA; Opezzo JA; Taira CA; Höcht C
J Pharmacol Toxicol Methods; 2008; 57(3):212-9. PubMed ID: 18442930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
